Armata Pharmaceuticals, Inc. Common Stock (ARMP)
Other Income/Expenses (Net)
$84.45M
Quarterly · Period ending: · USD

ARMP Other Income/Expenses (Net)
Latest reported$84.45Mperiod ending
Latest reported$84.45Mperiod ending
ARMP Quarterly Other Income/Expenses (Net) (-$1.30M → $84.45M)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
ARMP other income/expenses (net) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 84,453,000 | |
| -106,561,000 | |
| -110,475,000 | |
| -18,899,000 | |
| -9,451,000 | |
| 1,660,000 | |
| 13,139,000 | |
| 4,275,000 | |
| 20,900,000 | |
| -14,793,000 | |
| -10,268,000 | |
| -20,825,000 | |
| 6,082,000 | |
| -3,144,000 | |
| 14,000 | |
| 9,000 | |
| 5,000 | |
| 1,000 | |
| 1,000 | |
| 724,000 | |
| 2,000 | |
| -60,000 | |
| -171,000 | |
| -146,000 | |
| -120,000 | |
| -157,000 | |
| -873,000 | |
| -178,000 | |
| 959,000 | |
| -11,000 | |
| 132,000 | |
| 31,000 | |
| 2,000 | |
| -79,000 | |
| 13,000 | |
| -33,000 | |
| 1,923,000 | |
| 113,000 | |
| 1,808,000 | |
| 1,032,000 | |
| -262,000 | |
| 1,406,000 | |
| 636,000 | |
| 7,867,000 | |
| 13,361,000 | |
| -12,226,000 | |
| 3,193,000 | |
| 26,438,000 | |
| 17,621,000 | |
| -8,773,000 | |
| 11,818,000 | |
| -46,412,000 | |
| -8,519,000 | |
| -312,000 | |
| -58,000 | |
| 2,000 | |
| 10,000 | |
| -8,522,000 | |
| 209,000 | |
| 73,000 | |
| 125,000 | |
| -13,322,000 | |
| 277,000 | |
| 92,000 | |
| 29,935,000 | |
| 2,633,000 | |
| 21,000 | |
| 47,000 | |
| 38,000 | |
| 96,000 | |
| 180,000 | |
| -169,000 | |
| -29,000 | |
| -8,000 | |
| 1,013,000 | |
| -96,000 | |
| 4,000 | |
| -87,000 | |
| -328,000 | |
| 6,611,000 | |
| -310,000 | |
| 5,733,000 | |
| 4,511,000 | |
| -166,000 | |
| -180,000 | |
| 7,344,000 | |
| -5,193,000 | |
| -1,019,000 | |
| -111,000 | |
| 161,388 | |
| -28,075,000 | |
| 3,877,000 | |
| 2,650,000 | |
| -800,000 | |
| -11,900,000 | |
| -3,200,000 | |
| 2,700,000 | |
| -1,600,000 | |
| 200,000 | |
| 3,100,000 |